Quidel Corporation (QDEL)

15.72 +0.18  +1.16%  May 31, 8:00PM Go Pro
Watch this stock
View Full Chart QDEL Price Chart

Key Stats

Market Cap 520.19M
Revenue Growth -36.30%
Profit Margin 0.13%
Earnings Yield -0.76%
Dividend Yield 0.00%
Earnings Per Share TTM -0.12
PE Ratio
Price / Sales Ratio 3.798
52 Week High 19.37
52 Week Low 12.35
Beta 0.6359
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 31 Quidel to Present at Upcoming Conferences Marketwire
May 21 QUIDEL CORP /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change...
May 08 Great week for TE! closed $HLX $LINE shorts, $SCHL $QDEL longs for avg 5-day mkt neutral return of 4.2%! by TrendExhaustion
May 04 $QDEL 200 Day SMA Cross - Price crossed above 200 day SMA (15.9292). Confirmed by volume. by TradeIdeasQuant
May 03 $QDEL Canaccord Genuity raises its price target $4 to $25 on Buy-rated Quidel (March 26, 2012 9:09 AM) that's 60% upside. by nucats
May 03 $QDEL rsi(2) = 0.0077. oversold. tsf(5,9&15) under pps. yes js, time for bounce. popped up on my 'fat pitch' filter on stockfetcher by nucats
May 02 $QDEL looking pretty oversold here. Looking for a short term bounce. by ScholzCapital
Apr 30 QUIDEL CORP /DE/ Files SEC form 10-Q, Quarterly Report
Apr 27 Quidel Whiffs on Revenues
Apr 26 New Star Analyst Rankings for Quidel Corporation

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Diagnostic Substances

Quidel Corporation serves to enhance the health and well being of people around the globe through the discovery, development, manufacturing and marketing of rapid diagnostic solutions at the point of care (POC) in infectious diseases and reproductive health. Marketed under the leading brand name of QuickVue®, the portfolio currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, respiratory syncytial virus, Fecal Occult Blood, Strep A, pregnancy, bacterial vaginosis, infectious mononucleosis, H. pylori and Chlamydia. The firm sells products to physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics and wellness screening centers. It was founded in 1979 and is headquartered in San Diego, California.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Quidel Corporation is up 2.54% over the last year vs S&P 500 Total Return up 0.88%, Meridian Bioscience down 17.16%, and Accelr8 Technology down 51.98%.

  • QDEL Total Returns
  • ^SPXTR Total Returns
  • VIVO Total Returns
  • AXK Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring QDEL

Did Quidel Corporation make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

QDEL Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
QDEL 15.72 +0.18 +1.16% 513.91M
QCRH 11.97 +0.10 +0.80% 56.41M
QCOR 41.40 -0.16 -0.39% 2.643B
QCOM 57.31 -0.14 -0.24% 97.17B
QCCO 4.090 -0.00 -0.00% 70.51M
QBC 0.27 -0.03 -10.00% 23.05M
QBAK 1.94 +0.00 +0.00% 23.76M
QAI 27.30 +0.07 +0.26%
PW 8.95 +0.25 +2.87% 14.09M
PVTB 14.73 -0.08 -0.54% 1.073B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close